This review entitled “Innovations in the treatment of anaphylaxis: A review of recent data” explores innovative nasal and oral products under investigation for the outpatient emergency treatment of anaphylaxis.

An article published in the Journal of Allergy and Clinical Immunology this month sheds new light on the management of immediate hypersensitivity reactions to vaccines.  

Researchers assessed nut recognition in children with and without nut allergy and their parents or guardians.

SACN has released a report that reviews the current recommendations for feeding children aged 1 to 5 years.

A recent report by Food Standards Australia New Zealand (FSANZ) has revealed that last year, Australia had their lowest rate of allergen-related product recalls in almost a decade. This reduction suggests that FSANZ’s initiatives and tighter regulations in the food

Avid runner and allergy dad Luke Taylor completed the ultra marathon from Sheffield to Nottingham, covering a distance of 35 miles in just over seven hours, in aid of Anaphylaxis UK.

Anaphylaxis UK recently learned of the tragic death of Eamonn Hogan, aged 43, from Kilcoo, Northern Ireland.  Eamonn suffered a serious and unexpected anaphylactic reaction to a wasp sting on Tuesday 13th June.

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched new guidance on the use of adrenaline auto-injectors, including what steps to take in an emergency and updated advice on body positioning.

The British Society for Allergy and Clinical Immunology (BSACI) has announced the publication of the Adrenaline auto-injector prescription for patients at risk of anaphylaxis: BSACI guidance for primary care. The guidance, written by the BSACI, is for primary care healthcare professionals managing